Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. University of Maryland Greenebaum Cancer Center, Baltimore, MD, United States

Survival: 13.4 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: United States
City/State/Province: Baltimore, MD
Hospital: University of Maryland Greenebaum Cancer Center
Journal: Link
Date: 3/2009

Patients: This phase 2 study involved 45 men with castration-resistant prostate cancer. The median age was 69, ranging from 52 to 84 years of age.

Treatment: Patients were treated with the chemotherapy drug patupilone.

Toxicity: Grade 4 abdominal pain and dehydration were each reported once. The most common grade 3 toxicities were diarrhea, fatigue, vomiting and dehydration.

Results: The median overall survival was 13.4 months.

Support: This study was supported by research funds from Novartis Pharmaceuticals, which developed patupilone.

Correspondence: Dr. A. Hussain

E-mail to a Friend Email Physician More Information